Conditions: Central Abdominal Bulging
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 793
Healthy volunteers: yes

Brief summary:
This is a multi-center, randomized, double-blinded, placebo-controlled study evaluating the safety and efficacy of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese subjects.

Detailed description:

Arms:
arm 1: Experimental arm arm 2: Placebo comparator

Interventions: intervention 1: LIPO-202 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: